Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria

Journal of NeuroVirology

Volumn 20, Issue 4, 2014, Pages 380-387

  Akolo, Christopher ^a   Royal III, Walter ^a   Cherner, Mariana ^b   Okwuasaba, Kanayo ^c   Eyzaguirre, Lindsay ^a   Adebiyi, Ruxton ^c   Umlauf, Anya ^b   Hendrix, Terence ^b   Johnson, Joyce ^a   Abimiku, Alashl'e ^a   Blattner, William A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

Author keywords

Africa; AIDS; Neuropsychological

Indexed keywords

ADULT; ARTICLE; ATTENTION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ETHNICITY; EXECUTIVE FUNCTION; FEMALE; FINGER TAPPING TEST; HIV ASSOCIATED DEMENTIA; HUMAN; LEARNING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NIGERIA; PRIORITY JOURNAL; STROOP TEST; VERBAL BEHAVIOR; VIRUS LOAD; WORKING MEMORY; COGNITION DISORDERS; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; COGNITION DISORDERS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NIGERIA;

EID: 84904265341     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0254-6     Document Type: Article

References (26)

1. (NACA), National Agency for the Control of AIDS (2012) Global AIDS response, Country progress report
2. Anderson E, Zink W, Xiong H, Gendelman HE (2002) HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr 31(Suppl 2):S43-S54 (Pubitemid 35190558)
3. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799 (Pubitemid 350059308)
4. Berger JR, Moskowitz L, Fischl M, Kelley RE (1987) Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J 80:683-686 (Pubitemid 18010696)
5. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307-319 (Pubitemid 39277061)
6. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ (1999) Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13:1249-1253 (Pubitemid 29361096)
7. Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17:1539-1545 (Pubitemid 36900555)
8. Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I (1997) Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 54:416-424 (Pubitemid 27172861)
9. Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD, Spector SA, McCutchan JA (1987) Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med 107:828-836 (Pubitemid 18014233)
10. Grant I, Heaton RK, Atkinson JH (1995) Neurocognitive disorders in HIV-1 infection. HNRC Group. HIV Neurobehavioral Research Center. Curr Top Microbiol Immunol 202:11-32
11. Hall KS, Gao S, Emsley CL, Ogunniyi AO, Morgan O, Hendrie HC (2000) Community screening interview for dementia (CSI 'D'); performance in five disparate study sites. Int J Geriatr Psychiatr 15:521-531 (Pubitemid 30409994)
12. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, \Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
13. Joska JA, GHPRSDFA (2010) Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. 16
14. Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R, Njamnshi DM, Nchindap E, Franklin DR Jr, Ellis RJ, McCutchan JA, Binam F, Mbanya D, Heaton RK, Njamnshi AK (2010) HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 10:60
15. Mayeux R, Stern Y, Tang MX, Todak G, Marder K, Sano M, Richards M, Stein Z, Ehrhardt AA, Gorman JM (1993) Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology 43:176-182 (Pubitemid 23035377)
16. McArthur JC (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66:407-437
17. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43:2245-2252 (Pubitemid 23346956)
18. Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186(Suppl 2):S193-S198
19. Odiase F, Ogunrin O, Ogunniyi A (2006) Effect of progression of disease on cognitive performance in HIV/AIDS. J Natl Med Assoc 98:1260-1262 (Pubitemid 44167750)
20. Paddick SM, Longdon AR, Kisoli A, Dotchin C, Gray WK, Dewhurst F, Chaote P, Kalaria R, Jusabani AM, Walker R (2013) Dementia prevalence estimates in sub-Saharan Africa: comparison of two diagnostic criteria. Glob Health Action 6:19646
21. Report of a Working Group of the American Academy of Neurology AIDS Task Force (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41:778-785
22. Royal W III, Cherner M, Carr J, Habib AG, Akomolafe A, Abimiku A, Charurat M, Farley J, Oluyemisi A, Mamadu I, Johnson J, Ellis R, McCutchan JA, Grant I, Blattner WA (2012) Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. J Neurovirol 18:191-199
23. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001) HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990-1998. Neurology 56:257-260 (Pubitemid 32095372)
24. Salawu FK, Bwala SA, Wakil MA, Bani B, Bukbuk DN, Kida I (2008) Cognitive function in HIV-seropositive Nigerians without AIDS. J Neurol Sci 267:142-146 (Pubitemid 351248921)
25. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14:403 -418
26. UNAIDS (2012) Report on the Global AIDS epidemic